L'édition de cet ISBN n'est malheureusement plus disponible.
Afficher les exemplaires de cette édition ISBNIn the last decade, emergent technologies have enhanced our understanding of genomic, transcriptional, proteomic, epigenetic, and immune mechanisms in carcinogenesis. This improved understanding has enabled the development of targeted cancer therapies and personalized management, and transformed conventional treatment paradigms. It has provided the framework for the discovery of new targets, for validation of novel agents, for combination therapies predicated upon scientific rationale, and for clinical trials that have already markedly improved the prognosis and outcome of patients with cancer.
Over 37 chapters this volume of Translational Oncology series, Targeted Therapy in Translational Cancer Research:
We are on the threshold of translating discoveries in cancer biology into unprecedented durable responses and improved clinical outcomes in the majority of patients with cancer. In this unique time in history, the discovery of novel therapeutic approaches targeting the molecular basis of cancer will allow for implementation of precision medicine, with the promise of potentially curative, well tolerated, therapies. Targeted Therapy in Translational Cancer Research was written to increase the awareness and access of basic and clinical researchers, caregivers, and patients alike to cutting–edge bench to bedside and back breakthroughs, which have transformed the diagnosis, prognosis, and treatment of cancer.
The expert editor team and contributing authors provide an insightful overview to the novel therapeutic approaches targeting the molecular basis of cancer and allowing for the growth of precision medicine. This title is an essential resource for clinical and research oncologists and trainees, pharmacologic research and development professionals, biomedical scientists, and allied oncology professionals.
Translational Oncology Series
Series Editors
ROBERT C. BAST, MD
Vice President for Translational Research
The University of Texas MD Anderson Cancer Center
Houston, TX, USA
MAURIE MARKMAN, MD
Senior Vice President for Clinical Affairs
Cancer Treatment Centers of America
Clinical Professor of Medicine
Drexel University College of Medicine
Philadelphia, PA, USA
ERNEST HAWK, MD, MPH
Vice President, Division of OVP, Cancer Prevention and Population Sciences
The University of Texas MD Anderson Cancer Center
Houston, TX, USA
Other volumes in the Translational Oncology Series
Cancer Gene Therapy by Viral and Non–viral Vectors
Edited by Malcolm Brenner and Mien–Chie Hung
978–1–118–50162–7
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Frais de port :
Gratuit
Vers Etats-Unis
Description du livre Etat : Brand New. New. US edition. Excellent Customer Service. N° de réf. du vendeur ABEOCT23-110218
Description du livre Etat : New. N° de réf. du vendeur 18838328-n
Description du livre Etat : New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship from the US or other locations in India depending on your location and availability. N° de réf. du vendeur ABTR-54467
Description du livre Etat : New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. This item may ship from the US or our Overseas warehouse depending on your location and stock availability. We Ship to PO BOX Location also. N° de réf. du vendeur ABRR-54467
Description du livre Hardcover. Etat : new. N° de réf. du vendeur 9781118468579
Description du livre Etat : New. pp. 368. N° de réf. du vendeur 26372432894
Description du livre Etat : New. Brand New. N° de réf. du vendeur 9781118468579
Description du livre Etat : New. N° de réf. du vendeur 18838328-n
Description du livre Etat : New. pp. 368. N° de réf. du vendeur 373645345
Description du livre Etat : new. N° de réf. du vendeur d0d114f4bc16bd84d52e0a1e2cbd2123